OPKO Health (OPK) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

OPK Stock Forecast

OPKO Health stock forecast is as follows: an average price target of $3.50 (represents a 113.41% upside from OPK’s last price of $1.64) and a rating consensus of 'Buy', based on 10 wall street analysts offering a 1-year stock forecast.

OPK Price Target

The average price target for OPKO Health (OPK) is $3.50 based on 1-year price targets from 10 Wall Street analysts in the past 3 months, with a price target range of $4.00 to $3.00. This represents a potential 113.41% upside from OPK's last price of $1.64.

OPK Analyst Ratings

Buy

According to 10 Wall Street analysts, OPKO Health's rating consensus is 'Buy'. The analyst rating breakdown for OPK stock is 0 'Strong Buy' (0.00%), 5 'Buy' (50.00%), 5 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

OPKO Health Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Sep 17, 2024	Yi Chen	H.C. Wainwright	$3.00	$1.70	76.99%	82.93%
Dec 15, 2022	-	H.C. Wainwright	$3.00	$1.29	132.56%	82.93%
Aug 04, 2022	Edward Tenthoff	Piper Sandler	$4.00	$2.40	66.67%	143.90%

Row per page

Go to

The latest OPKO Health stock forecast, released on Sep 17, 2024 by Yi Chen from H.C. Wainwright, set a price target of $3.00, which represents a 76.99% increase from the stock price at the time of the forecast ($1.70), and a 82.93% increase from OPK last price ($1.64).

OPKO Health Price Target by Period

	1M	3M	12M
# Anlaysts	-	1	1
Avg Price Target	-	$3.00	$3.00
Last Closing Price	$1.64	$1.64	$1.64
Upside/Downside	-100.00%	82.93%	82.93%

In the current month, the average price target of OPKO Health stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to OPKO Health's last price of $1.64. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Sep 17, 2024	Sandler O'Neill	Buy	Buy	Hold
Sep 17, 2024	Piper Sandler	Overweight	Overweight	Hold
Sep 17, 2024	New Street	Buy	Buy	Hold
Sep 17, 2024	H.C. Wainwright	Buy	Buy	Hold
Apr 01, 2024	Piper Sandler	Buy	Buy	Hold
Jun 29, 2023	JMP Securities	-	Market Perform	Initialise
Jun 29, 2023	Guggenheim	-	Neutral	Initialise
Jun 29, 2023	Susquehanna	-	Positive	Upgrade
Jun 29, 2023	Piper Sandler	Overweight	Neutral	Upgrade
Jun 29, 2023	UBS	-	Neutral	Downgrade

Row per page

Go to

OPKO Health's last stock rating was published by Sandler O'Neill on Sep 17, 2024. The company gave OPK a "Buy" rating, the same as its previous rate.

OPKO Health Financial Forecast

OPKO Health Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$181.88M	$178.59M	$265.42M	$237.60M	$185.40M	$179.74M	$309.89M	$329.22M	$401.33M	$385.81M	$442.41M	$545.16M	$494.67M	$428.06M	$301.21M	$211.47M	$224.34M	$228.77M
Avg Forecast	$178.80M	$167.80M	$170.40M	$166.60M	$174.93M	$166.38M	$162.60M	$156.38M	$155.42M	$181.52M	$184.70M	$182.99M	$177.53M	$174.78M	$201.97M	$193.35M	$168.21M	$183.51M	$326.87M	$332.62M	$329.83M	$302.27M	$456.36M	$494.16M	$443.10M	$378.66M	$245.60M	$218.00M	$216.07M	$225.40M
High Forecast	$184.24M	$172.90M	$175.58M	$171.67M	$180.25M	$171.44M	$167.55M	$162.93M	$162.70M	$181.52M	$190.32M	$182.99M	$179.18M	$174.78M	$208.11M	$199.23M	$173.33M	$183.51M	$326.87M	$332.62M	$329.83M	$302.27M	$456.36M	$494.16M	$443.10M	$378.66M	$245.60M	$218.00M	$216.07M	$225.40M
Low Forecast	$173.13M	$162.47M	$164.99M	$161.31M	$169.37M	$161.09M	$157.44M	$147.96M	$151.22M	$181.52M	$178.84M	$182.99M	$175.90M	$174.78M	$195.56M	$187.22M	$162.87M	$183.51M	$326.87M	$332.62M	$329.83M	$302.27M	$456.36M	$494.16M	$443.10M	$378.66M	$245.60M	$218.00M	$216.07M	$225.40M
# Analysts	1	1	1	1	1	1	1	3	5	4	4	4	5	4	4	4	3	3	3	3	4	4	4	4	9	9	9	9	13	13
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.02%	1.02%	1.31%	1.23%	1.10%	0.98%	0.95%	0.99%	1.22%	1.28%	0.97%	1.10%	1.12%	1.13%	1.23%	0.97%	1.04%	1.01%

OPKO Health's average Quarter revenue forecast for Mar 24 based on 4 analysts is $182.99M, with a low forecast of $182.99M, and a high forecast of $182.99M. OPK's average Quarter revenue forecast represents a 0.61% increase compared to the company's last Quarter revenue of $181.88M (Dec 23).

OPKO Health EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	5	4	4	4	5	4	4	4	3	3	3	3	4	4	4	4	9	9	9	9	13	13
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$-161.06M	$-64.41M	$13.20M	$-8.90M	$-41.30M	$-98.17M	$-70.77M	$-46.15M	$-42.78M	$54.67M	$14.03M	$57.02M	$71.38M	$47.06M	$67.47M	$-30.41M	$-80.93M	$-30.64M
Avg Forecast	$-14.73M	$-13.82M	$-14.04M	$-13.72M	$-14.41M	$-13.70M	$-13.39M	$-12.88M	$-12.80M	$-14.95M	$-15.21M	$-37.29M	$-14.62M	$-14.40M	$-16.64M	$-33.90M	$-148.23M	$-8.20M	$-14.61M	$-30.82M	$-14.74M	$-13.51M	$-20.40M	$57.02M	$-19.80M	$-16.92M	$-10.98M	$-30.41M	$-9.66M	$-10.07M
High Forecast	$-14.26M	$-13.38M	$-13.59M	$-13.29M	$-13.95M	$-13.27M	$-12.97M	$-12.19M	$-12.46M	$-14.95M	$-14.73M	$-29.83M	$-14.49M	$-14.40M	$-16.11M	$-27.12M	$-118.58M	$-8.20M	$-14.61M	$-24.65M	$-14.74M	$-13.51M	$-20.40M	$68.43M	$-19.80M	$-16.92M	$-10.98M	$-24.33M	$-9.66M	$-10.07M
Low Forecast	$-15.18M	$-14.24M	$-14.46M	$-14.14M	$-14.85M	$-14.12M	$-13.80M	$-13.42M	$-13.40M	$-14.95M	$-15.68M	$-44.74M	$-14.76M	$-14.40M	$-17.14M	$-40.68M	$-177.88M	$-8.20M	$-14.61M	$-36.98M	$-14.74M	$-13.51M	$-20.40M	$45.62M	$-19.80M	$-16.92M	$-10.98M	$-36.50M	$-9.66M	$-10.07M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	11.01%	4.47%	-0.79%	0.26%	0.28%	11.97%	4.84%	1.50%	2.90%	-4.05%	-0.69%	1.00%	-3.60%	-2.78%	-6.15%	1.00%	8.38%	3.04%

4 analysts predict OPK's average Quarter EBITDA for Sep 23 to be $-14.40M, with a high of $-14.40M and a low of $-14.40M. This is -209.08% lower than OPKO Health's previous annual EBITDA (Jun 23) of $13.20M.

OPKO Health Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	5	4	4	4	5	4	4	4	3	3	3	3	4	4	4	4	9	9	9	9	13	13
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$-66.52M	$-84.47M	$-19.64M	$-18.20M	$-85.20M	$-86.05M	$-101.38M	$-55.38M	$-73.31M	$28.74M	$-16.19M	$31.08M	$32.30M	$23.72M	$33.70M	$-59.13M	$-112.35M	$-62.01M
Avg Forecast	$-49.92M	$-59.90M	$-59.90M	$-59.90M	$-67.39M	$-69.89M	$-72.38M	$-77.37M	$-79.87M	$-93.18M	$-94.84M	$-44.72M	$-99.84M	$-99.84M	$-71.55M	$-40.65M	$-255.63M	$-58.57M	$5.58M	$-36.96M	$-13.94M	$-6.97M	$12.55M	$31.08M	$29.28M	$30.68M	$-46.02M	$-59.13M	$-61.01M	$-62.75M
High Forecast	$-47.86M	$-57.43M	$-57.43M	$-57.43M	$-64.61M	$-67.00M	$-69.39M	$-38.69M	$-29.95M	$-89.34M	$-90.93M	$-35.77M	$-88.74M	$-95.72M	$-68.60M	$-32.52M	$-204.50M	$-58.57M	$5.58M	$-29.56M	$-13.94M	$-6.97M	$12.55M	$37.29M	$29.28M	$30.68M	$-46.02M	$-47.31M	$-61.01M	$-62.75M
Low Forecast	$-51.89M	$-62.27M	$-62.27M	$-62.27M	$-70.05M	$-72.65M	$-75.24M	$-116.06M	$-149.75M	$-96.86M	$-98.59M	$-53.66M	$-110.93M	$-103.78M	$-74.38M	$-48.78M	$-306.75M	$-58.57M	$5.58M	$-44.35M	$-13.94M	$-6.97M	$12.55M	$24.86M	$29.28M	$30.68M	$-46.02M	$-70.96M	$-61.01M	$-62.75M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.67%	0.85%	0.27%	0.45%	0.33%	1.47%	-18.18%	1.50%	5.26%	-4.12%	-1.29%	1.00%	1.10%	0.77%	-0.73%	1.00%	1.84%	0.99%

OPKO Health's average Quarter net income forecast for Dec 21 is $-13.94M, with a range of $-13.94M to $-13.94M. OPK's average Quarter net income forecast represents a -148.52% decrease compared to the company's last Quarter net income of $28.74M (Sep 21).

OPKO Health SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	5	4	4	4	5	4	4	4	3	3	3	3	4	4	4	4	9	9	9	9	13	13
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$72.77M	$72.24M	$79.79M	$75.70M	$74.00M	$79.67M	$101.46M	$117.54M	$138.21M	$105.12M	$113.24M	$112.29M	$101.82M	$99.90M	$77.72M	$76.13M	$79.13M	$80.54M
Avg Forecast	$57.64M	$54.09M	$54.93M	$53.71M	$56.39M	$53.63M	$52.42M	$50.41M	$50.10M	$58.52M	$59.54M	$94.81M	$57.23M	$56.34M	$65.11M	$86.19M	$54.22M	$59.16M	$105.37M	$78.36M	$106.32M	$97.44M	$147.11M	$112.29M	$142.84M	$122.07M	$79.17M	$76.13M	$69.65M	$72.66M
High Forecast	$59.39M	$55.74M	$56.60M	$55.34M	$58.10M	$55.26M	$54.01M	$52.52M	$52.45M	$58.52M	$61.35M	$113.78M	$57.76M	$56.34M	$67.09M	$103.43M	$55.87M	$59.16M	$105.37M	$94.03M	$106.32M	$97.44M	$147.11M	$134.74M	$142.84M	$122.07M	$79.17M	$91.36M	$69.65M	$72.66M
Low Forecast	$55.81M	$52.38M	$53.19M	$52.00M	$54.60M	$51.93M	$50.75M	$47.70M	$48.75M	$58.52M	$57.65M	$75.85M	$56.70M	$56.34M	$63.04M	$68.96M	$52.50M	$59.16M	$105.37M	$62.69M	$106.32M	$97.44M	$147.11M	$89.83M	$142.84M	$122.07M	$79.17M	$60.91M	$69.65M	$72.66M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.27%	1.28%	1.23%	0.88%	1.36%	1.35%	0.96%	1.50%	1.30%	1.08%	0.77%	1.00%	0.71%	0.82%	0.98%	1.00%	1.14%	1.11%

OPKO Health's average Quarter SG&A projection for Mar 24 is $94.81M, based on 4 Wall Street analysts, with a range of $75.85M to $113.78M. The forecast indicates a 30.30% rise compared to OPK last annual SG&A of $72.77M (Dec 23).

OPKO Health EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	5	4	4	4	5	4	4	4	3	3	3	3	4	4	4	4	9	9	9	9	13	13
EPS	-	-	-	-	-	-	-	-	-	-	-	-	$-8.85	$-0.11	$-0.03	$-0.02	$-0.11	$-0.11	$-0.14	$-0.08	$-0.11	$0.04	$-0.03	$0.05	$0.05	$0.04	$0.05	$-0.09	$-0.18	$-0.11
Avg Forecast	$-0.05	$-0.06	$-0.06	$-0.06	$-0.07	$-0.07	$-0.07	$-0.08	$-0.08	$-0.09	$-0.10	$-0.10	$-0.10	$-0.10	$-0.07	$-0.08	$-0.11	$-0.08	$0.01	$-0.06	$-0.02	$-0.01	$0.02	$0.05	$0.04	$0.04	$-0.07	$-0.09	$-0.09	$-0.09
High Forecast	$-0.05	$-0.06	$-0.06	$-0.06	$-0.06	$-0.07	$-0.07	$-0.04	$-0.03	$-0.09	$-0.09	$-0.09	$-0.09	$-0.10	$-0.07	$-0.07	$-0.11	$-0.08	$0.01	$-0.06	$-0.02	$-0.01	$0.02	$0.05	$0.04	$0.04	$-0.07	$-0.09	$-0.09	$-0.09
Low Forecast	$-0.05	$-0.06	$-0.06	$-0.06	$-0.07	$-0.07	$-0.08	$-0.12	$-0.15	$-0.10	$-0.10	$-0.10	$-0.11	$-0.10	$-0.07	$-0.08	$-0.12	$-0.08	$0.01	$-0.06	$-0.02	$-0.01	$0.02	$0.05	$0.04	$0.04	$-0.07	$-0.09	$-0.09	$-0.09
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	88.50%	1.10%	0.36%	0.32%	0.99%	1.31%	-17.50%	1.50%	5.50%	-4.00%	-1.67%	1.04%	1.19%	0.91%	-0.76%	1.03%	2.06%	1.22%

According to 4 Wall Street analysts, OPKO Health's projected average Quarter EPS for Dec 21 is $-0.02, with a low estimate of $-0.02 and a high estimate of $-0.02. This represents a -150.00% decrease compared to OPK previous annual EPS of $0.04 (Sep 21).

OPKO Health Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
DMTK	DermTech	$0.09	$15.00	16566.67%	Buy
TTOO	T2 Biosystems	$0.51	$5.00	880.39%	Hold
FLGT	Fulgent Genetics	$16.71	$45.00	169.30%	Buy
BDSX	Biodesix	$1.26	$3.00	138.10%	Buy
OPK	OPKO Health	$1.64	$3.50	113.41%	Buy
GH	Guardant Health	$28.96	$57.27	97.76%	Buy
ILMN	Illumina	$130.74	$202.44	54.84%	Buy
CSTL	Castle Biosciences	$27.90	$40.50	45.16%	Buy
CDNA	CareDx	$21.56	$29.75	37.99%	Buy
ME	23andMe	$2.83	$3.71	31.10%	Buy
A	Agilent	$126.92	$152.64	20.26%	Buy
IDXX	IDEXX Laboratories	$419.83	$479.75	14.27%	Buy
TWST	Twist Bioscience	$41.43	$42.40	2.34%	Buy
NTRA	Natera	$153.42	$120.92	-21.18%	Buy

OPK Forecast FAQ

Is OPKO Health a good buy?

Yes, according to 10 Wall Street analysts, OPKO Health (OPK) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 50.00% of OPK's total ratings.

What is OPK's price target?

OPKO Health (OPK) average price target is $3.5 with a range of $3 to $4, implying a 113.41% from its last price of $1.64. The data is based on 10 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will OPKO Health stock go up soon?

According to Wall Street analysts' prediction for OPK stock, the company can go up by 113.41% (from the last price of $1.64 to the average price target of $3.5), up by 143.90% based on the highest stock price target, and up by 82.93% based on the lowest stock price target.

Can OPKO Health stock reach $2?

OPK's average twelve months analyst stock price target of $3.5 supports the claim that OPKO Health can reach $2 in the near future.

What are OPKO Health's analysts' financial forecasts?

OPKO Health's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $660.28M (high $682.16M, low $635.87M), average EBITDA is $-54.384M (high $-52.374M, low $-56.187M), average net income is $-287M (high $-240M, low $-334M), average SG&A $212.85M (high $219.9M, low $204.98M), and average EPS is $-0.288 (high $-0.24, low $-0.335). OPK's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $683.6M (high $704.39M, low $661.9M), average EBITDA is $-56.306M (high $-54.519M, low $-58.018M), average net income is $-230M (high $-220M, low $-239M), average SG&A $220.37M (high $227.07M, low $213.37M), and average EPS is $-0.23 (high $-0.221, low $-0.239).

Did the OPK's actual financial results beat the analysts' financial forecasts?

Based on OPKO Health's last annual report (Dec 2023), the company's revenue was $863.5M, beating the average analysts forecast of $747.63M by 15.50%. Apple's EBITDA was $-157M, beating the average prediction of $-79.551M by 97.38%. The company's net income was $-189M, missing the average estimation of $-312M by -39.44%. Apple's SG&A was $300.56M, beating the average forecast of $264.87M by 13.47%. Lastly, the company's EPS was $-25.12, beating the average prediction of $-0.348 by 7111.47%. In terms of the last quarterly report (Dec 2023), OPKO Health's revenue was $181.88M, beating the average analysts' forecast of $177.53M by 2.45%. The company's EBITDA was $-161M, beating the average prediction of $-14.623M by 1001.46%. OPKO Health's net income was $-66.523M, missing the average estimation of $-99.836M by -33.37%. The company's SG&A was $72.76M, beating the average forecast of $57.23M by 27.15%. Lastly, the company's EPS was $-8.85, beating the average prediction of $-0.1 by 8750.00%